Scholarlink

<p>Accumulating evidence supports the beneficial effects of probiotics in regulating glucose and lipid metabolism; however, the underlying mechanisms of certain probiotic strains in diabetes remain unclear. The purpose of this study was to evaluate the anti-diabetic effects of <i>Bifidobacterium longum</i> TISTR 2893 in a high-fat diet (HFD)-induced type 2 diabetic (T2D) rat model, combined with a low dose of streptozotocin (STZ). Additionally, the <i>B. longum</i> TISTR 2893’s effects on hepatic carbohydrate metabolism pathways were examined. The results demonstrated that <i>B. longum</i> TISTR 2893 treatment significantly suppressed fasting blood glucose (FBG) elevation and excessive water intake in the diabetic rats, while also enhancing glucose clearance following oral glucose loading. Moreover, <i>B. longum</i> TISTR 2893 improved pancreatic islet structure, which was associated with the suppression of pancreatic TNF-α and oxidative stress. <i>Bifidobacterium longum</i> TISTR 2893 also significantly alleviated diabetes-induced hepatic steatosis, as evidenced by reductions in hepatic triglyceride levels and Oil Red O staining intensity. Furthermore, <i>B. longum</i> TISTR 2893 modulated hepatic glucose metabolism by enhancing hexokinase activity, glycogen storage, and the expression of phospho-glycogen synthase kinase-3β (p-GSK-3β) and protein kinase B (AKT/PKB), while markedly inhibiting gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase-1 (PCK-1) expression and fructose-1,6-bisphosphatase (FBPase) activity. Additionally, <i>B. longum</i> TISTR 2893 exhibited antioxidant effects in the livers of the diabetic rats. In conclusion, these findings suggest that <i>B. longum</i> TISTR 2893 may exert hypoglycemic effects in T2D rats through the activation of AKT-mediated hepatic carbohydrate metabolism, which is linked to its antioxidative defense mechanisms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bifidobacterium longum TISTR 2893 Regulates Glycemic Homeostasis by Modulating the Hepatic Carbohydrate Metabolism in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats

  • 期刊论文

  • 发表日期：

    2025年7月25日

查看全文
  • Kanokpron Tasa,
  • Pennapa Chonpathompikunlert,
  • Navinee Wongmanee,
  • Worarat Rojanaverawong,
  • Suthkamol Suttikul,
  • Tantima Kumlung,
  • Thanyarat Lekchaoum,
  • Wanthanee Hanchang

摘要

Accumulating evidence supports the beneficial effects of probiotics in regulating glucose and lipid metabolism; however, the underlying mechanisms of certain probiotic strains in diabetes remain unclear. The purpose of this study was to evaluate the anti-diabetic effects of Bifidobacterium longum TISTR 2893 in a high-fat diet (HFD)-induced type 2 diabetic (T2D) rat model, combined with a low dose of streptozotocin (STZ). Additionally, the B. longum TISTR 2893’s effects on hepatic carbohydrate metabolism pathways were examined. The results demonstrated that B. longum TISTR 2893 treatment significantly suppressed fasting blood glucose (FBG) elevation and excessive water intake in the diabetic rats, while also enhancing glucose clearance following oral glucose loading. Moreover, B. longum TISTR 2893 improved pancreatic islet structure, which was associated with the suppression of pancreatic TNF-α and oxidative stress. Bifidobacterium longum TISTR 2893 also significantly alleviated diabetes-induced hepatic steatosis, as evidenced by reductions in hepatic triglyceride levels and Oil Red O staining intensity. Furthermore, B. longum TISTR 2893 modulated hepatic glucose metabolism by enhancing hexokinase activity, glycogen storage, and the expression of phospho-glycogen synthase kinase-3β (p-GSK-3β) and protein kinase B (AKT/PKB), while markedly inhibiting gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase-1 (PCK-1) expression and fructose-1,6-bisphosphatase (FBPase) activity. Additionally, B. longum TISTR 2893 exhibited antioxidant effects in the livers of the diabetic rats. In conclusion, these findings suggest that B. longum TISTR 2893 may exert hypoglycemic effects in T2D rats through the activation of AKT-mediated hepatic carbohydrate metabolism, which is linked to its antioxidative defense mechanisms.